Click here for PDF of Symposium Program
| PRELIMINARY PROGRAM | | 10.00 | Welcome
Anthony D. Ho, Christof von Kalle, Eike Martin, Hartmut Goldschmidt
| | 10.15 - 11.30 | New developments in diagnostics | | 10.15 – 10.40 | Molecular cytogenetics
Friedrich Cremer
| | 10.40 – 11.05 | Gene expression profiling: biology of myeloma and clinical application
Bernard Klein
| | 11.05 – 11.30 | PET and MRI
Brian Durie
| | 11.30 – 11.50 | Break | | 11.50 – 13.30 | New Treatment Modalities | | 11.50 – 12.15 | Thalidomide
Axel Glasmacher
| | 12.15 – 12.40 | Velcade
Pieter Sonneveld
| | 12.40 – 13.05 | Revlimid
Hartmut Goldschmidt
| | 13.05 – 13.30 | Allogeneic transplantation
Nicolaus Kroeger (not confirmed)
| | 13.30 – 14.30 | Break | | 14.30 – 17.30 | Business Meeting of the GMMG study group - Part I: Diagnostics
- Molecular cytogenetics – Peter Liebisch (asked) /Friedrich W. Cremer
- Bone marrow histology – Reiner Bartl
- Gene expression – Friedrich W. Cremer
- Break
- Part II: Ongoing trials and first results
- GMMG-HD2 and -HD3 – Hartmut Goldschmidt
- GMMG-HD4 – Uta Mazitschek
- GMMG65 – Wolfgang Knauf
- HD-AL2 – Stefan Schönland
- NMAM2000 – Ute Hegenbart
- TCID – Axel Glasmacher
- Bendamustin plus Thalidomid – Wolfgang Pönisch
- HOVON Data – Pieter Sonneveld
- DSMM Data– Christian Straka (asked)
- CEMSG – Heinz Ludwig
| | 18.00 | Tour of Heidelberg castle and “Apothekermuseum” | | 19.30 | Dinner at the Castle, Restaurant “Schönmehl” |
Click here for PDF of Symposium Program
|
print